Literature DB >> 8522382

Properties of Escherichia coli strains of serotype O6.

G Blum1, R Marre, J Hacker.   

Abstract

Escherichia coli isolates of serotype O6 show a broad spectrum of virulence: virulent strains often cause urinary tract infections; other strains are considered nonpathogenic. In order to analyze the properties of E. coli O6 strains, different phenotypic and genotypic test systems were used. Our data indicate that O6 strains represent a rather heterogenous group of bacteria, which differ in the genotypic presence as well as in the phenotypic expression of virulence factors. In contrast to the isolates 536 (O6:K15) and RZ 475 (O6:K5) the strain DSm 6601, belonging to serotype O6:K5:H1, produces neither toxins nor mannose-resistant hemagglutinating (MRHA) adhesins. However, the strain possesses chromosomally located gene clusters coding for F1C (foc) and type I fimbriae (fim). In addition, the strain secrets the iron-uptake substances aerobactin and enterobactin and produces at least one microcin. The strain is serum-sensitive and is less virulent in in vivo animal tests.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522382     DOI: 10.1007/bf01781204

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  Clonal analysis of Escherichia coli serotype O6 strains from urinary tract infections.

Authors:  G Zingler; M Ott; G Blum; U Falkenhagen; G Naumann; W Sokolowska-Köhler; J Hacker
Journal:  Microb Pathog       Date:  1992-04       Impact factor: 3.738

2.  Virulence patterns and long-range genetic mapping of extraintestinal Escherichia coli K1, K5, and K100 isolates: use of pulsed-field gel electrophoresis.

Authors:  M Ott; L Bender; G Blum; M Schmittroth; M Achtman; H Tschäpe; J Hacker
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Virulence determinants of Escherichia coli O6 extraintestinal isolates analysed by Southern hybridizations and DNA long range mapping techniques.

Authors:  G Blum; M Ott; A Cross; J Hacker
Journal:  Microb Pathog       Date:  1991-02       Impact factor: 3.738

Review 4.  Escherichia coli in extra-intestinal infections.

Authors:  I Orskov; F Orskov
Journal:  J Hyg (Lond)       Date:  1985-12

Review 5.  Genetic aspects of Escherichia coli virulence.

Authors:  I Mühldorfer; J Hacker
Journal:  Microb Pathog       Date:  1994-03       Impact factor: 3.738

6.  Gene clusters encoding the cytotoxic necrotizing factor type 1, Prs-fimbriae and alpha-hemolysin form the pathogenicity island II of the uropathogenic Escherichia coli strain J96.

Authors:  G Blum; V Falbo; A Caprioli; J Hacker
Journal:  FEMS Microbiol Lett       Date:  1995-02-15       Impact factor: 2.742

7.  Evidence for two types of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli.

Authors:  J De Rycke; E A González; J Blanco; E Oswald; M Blanco; R Boivin
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

8.  Clonal differentiation of uropathogenic Escherichia coli isolates of serotype O6:K5 by fimbrial antigen typing and DNA long-range mapping techniques.

Authors:  G Zingler; G Blum; U Falkenhagen; I Orskov; F Orskov; J Hacker; M Ott
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

9.  Excision of large DNA regions termed pathogenicity islands from tRNA-specific loci in the chromosome of an Escherichia coli wild-type pathogen.

Authors:  G Blum; M Ott; A Lischewski; A Ritter; H Imrich; H Tschäpe; J Hacker
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model.

Authors:  R Marre; J Hacker; W Henkel; W Goebel
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

  10 in total
  30 in total

1.  Type 1 fimbriation and phase switching in a natural Escherichia coli fimB null strain, Nissle 1917.

Authors:  B Stentebjerg-Olesen; T Chakraborty; P Klemm
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  Promising discovery of beneficial Escherichia coli in the human gut.

Authors:  Atchareeya Nakkarach; Hooi Ling Foo; Adelene Ai-Lian Song; Sunee Nitisinprasert; Ulaiwan Withayagiat
Journal:  3 Biotech       Date:  2020-06-09       Impact factor: 2.406

3.  Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.

Authors:  A Grabig; D Paclik; C Guzy; A Dankof; D C Baumgart; J Erckenbrecht; B Raupach; U Sonnenborn; J Eckert; R R Schumann; B Wiedenmann; A U Dignass; A Sturm
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation.

Authors:  Ana Cristina Hernando-Harder; Rudolf von Bünau; Mahaluxmy Nadarajah; Manfred Vincenz Singer; Hermann Harder
Journal:  Dig Dis Sci       Date:  2007-08-22       Impact factor: 3.199

Review 5.  Probiotics: properties, examples, and specific applications.

Authors:  Judith Behnsen; Elisa Deriu; Martina Sassone-Corsi; Manuela Raffatellu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

6.  How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.

Authors:  Elzbieta Brzuszkiewicz; Holger Brüggemann; Heiko Liesegang; Melanie Emmerth; Tobias Olschläger; Gábor Nagy; Kaj Albermann; Christian Wagner; Carmen Buchrieser; Levente Emody; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

7.  NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

Authors:  Jan Wehkamp; Jürgen Harder; Kai Wehkamp; Birte Wehkamp-von Meissner; Miriam Schlee; Corinne Enders; Ulrich Sonnenborn; Sabine Nuding; Stig Bengmark; Klaus Fellermann; Jens Michael Schröder; Eduard F Stange
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917.

Authors:  Lubomir Grozdanov; Carsten Raasch; Jürgen Schulze; Ulrich Sonnenborn; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

9.  Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection.

Authors:  Sylvia Kleta; Marcel Nordhoff; Karsten Tedin; Lothar H Wieler; Rafal Kolenda; Sibylle Oswald; Tobias A Oelschlaeger; Wilfried Bleiss; Peter Schierack
Journal:  Infect Immun       Date:  2014-02-18       Impact factor: 3.441

10.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.